Common Contracts
2 similar Metallophile™ Technology License Agreement contracts by Viamet Pharmaceuticals Holdings LLC
METALLOPHILE™ TECHNOLOGY LICENSE AGREEMENTMetallophile™ Technology License Agreement • April 8th, 2016 • Viamet Pharmaceuticals Holdings LLC • Pharmaceutical preparations • Delaware
This Metallophile™ Technology License Agreement (“Agreement”), effective as of October 13, 2014 (the “Effective Date”), is entered into by and between VPS-1, Inc., a Delaware corporation with a principal place of business at 4505 Emperor Blvd., Suite 300, Durham, North Carolina 27703 (“Primary”), and Innocrin Pharmaceuticals, Inc. (originally incorporated as Hephestics, Inc. and formerly known as Viamet Pharmaceuticals, Inc.), a Delaware corporation with a principal place of business at 4505 Emperor Blvd., Suite 300, Durham, North Carolina 27703 (“Legacy”). Primary and Legacy may collectively be referred to as the “Parties” (and each, as a “Party”).
METALLOPHILE™ TECHNOLOGY LICENSE AGREEMENTMetallophile™ Technology License Agreement • February 1st, 2016 • Viamet Pharmaceuticals Holdings LLC • Pharmaceutical preparations • Delaware
This Metallophile™ Technology License Agreement (“Agreement”), effective as of October 13, 2014 (the “Effective Date”), is entered into by and between VPS-1, Inc., a Delaware corporation with a principal place of business at 4505 Emperor Blvd., Suite 300, Durham, North Carolina 27703 (“Primary”), and Innocrin Pharmaceuticals, Inc. (originally incorporated as Hephestics, Inc. and formerly known as Viamet Pharmaceuticals, Inc.), a Delaware corporation with a principal place of business at 4505 Emperor Blvd., Suite 300, Durham, North Carolina 27703 (“Legacy”). Primary and Legacy may collectively be referred to as the “Parties” (and each, as a “Party”).
